ストックスクリーナーアプリを入手
4.00
4.98%
0.1899
前日終値:
$3.8101
開ける：
$4
24時間の取引高:
292
Relative Volume:
0.02
時価総額：
$46.55M
収益：
$291.44M
当期純損益:
$-44.17M
株価収益率:
-0.9524
EPS:
-4.2
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.48%
1か月 パフォーマンス:
-19.19%
6か月 パフォーマンス:
-2.79%
1年 パフォーマンス:
-1.23%
1日の値動き範囲:
$4.00
$4.00
1週間の範囲:
$3.62
$4.54
52週間の値動き範囲:
$2.85
$7.838
Prenetics Global Limited Stock (PRE) Company Profile
PRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRE
Prenetics Global Limited
|
4.00 | 46.55M | 291.44M | -44.17M | 0 | -4.20 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Prenetics Global Limited Stock (PRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-18 | 開始されました | Cantor Fitzgerald | Overweight |
Prenetics Global Limited (PRE) 最新ニュース
(PRE) On The My Stocks Page - Stock Traders Daily
What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash - Simply Wall St
Prenetics’ IM8 Health Expands Scientific Advisory Board, - GlobeNewswire
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market - Marketscreener.com
Prenetics to Participate in the 37th Annual ROTH Conference - GlobeNewswire
Prenetics to Participate in the 37th Annual ROTH Conference -March 11, 2025 at 08:31 am EDT - Marketscreener.com
Prenetics Executives Reveal Growth Strategy at ROTH Conference Longevity Panel - StockTitan
FY2024 EPS Forecast for Prenetics Global Reduced by Analyst - Defense World
Short Interest in Prenetics Global Limited (NASDAQ:PRE) Grows By 22.1% - Defense World
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance - GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance | - Digital More
Prenetics Reports Strong 2024 Results and Optimistic 2025 Outlook - TipRanks
Financial Contrast: Telesis Bio (NASDAQ:TBIO) and Prenetics Global (NASDAQ:PRE) - Defense World
Comparing Prenetics Global (NASDAQ:PRE) & PositiveID (OTCMKTS:PSID) - Armenian Reporter
Prenetics Global Limited (NASDAQ:PRE) Short Interest Down 24.7% in January - MarketBeat
Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) Head to Head Analysis - Defense World
Prenetics Expands into Web3 with Blockchain Identity Partnership - CoinTrust
Prenetics, Humanity Protocol partner for DNA ID - Tech in Asia
Nasdaq-Listed Prenetics Announces Genomics-Based - GlobeNewswire
PREPrenetics Ltd Latest Stock News & Market Updates - StockTitan
Nasdaq-Listed Prenetics Enters Crypto Space with Humanity Protocol Partnership - Coinspeaker
Prenetics Partners with Humanity Protocol to Enhance Blockchain-Based Identity Verification and Invests in Digital Assets - Nasdaq
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve - Marketscreener.com
Prenetics DNA Testing Giant Enters Web3: Teams Up With $1.1B Humanity Protocol, Backs Bitcoin - StockTitan
FY2025 Earnings Forecast for PRE Issued By Cantor Fitzgerald - Defense World
Trend Tracker for (PRE) - Stock Traders Daily
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham - GlobeNewswire
David Beckham Launches IM8 Premium Wellness Brand with Deepak Chopra in Star-Studded NYC Event - StockTitan
Prenetics Global (NASDAQ:PRE) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials - GlobeNewswire
David Beckham's IM8 Supplements Earn Elite NSF Sport Certification for Ultimate Daily Formula - StockTitan
When (PRE) Moves Investors should Listen - Stock Traders Daily
Financial Comparison: Prenetics Global (NASDAQ:PRE) and 10x Genomics (NASDAQ:TXG) - Defense World
Where are the Opportunities in (PRE) - Stock Traders Daily
Short Interest in Prenetics Global Limited (NASDAQ:PRE) Rises By 23.6% - MarketBeat
Prenetics Global (NASDAQ:PRE) Trading Down 1.6%What's Next? - MarketBeat
Prenetics Global (NASDAQ:PRE) Shares Down 1.6% – Here’s Why - Defense World
Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - The Manila Times
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - GlobeNewswire
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce - Simply Wall St
Precision Nutrition Industry Assessment and Forecast to 2029: Revenues Anticipated to Reach $12.9 BillionCase Study Analysis Featuring 23AndMe, Genesis Healthcare Co, and Viome Life Sciences - GlobeNewswire
Prenetics Global Announces 2024 Annual General Meeting - TipRanks
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 - Financial Content
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - The Manila Times
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - GlobeNewswire
Prenetics Announces Participation in December Investor Conferences - The Manila Times
Prenetics Global CEO to Present at iAccess Alpha Conference; Set for ROTH Deer Valley Event - StockTitan
Contrasting Prenetics Global (NASDAQ:PRE) and Standard BioTools (NASDAQ:LAB) - Defense World
Prenetics Global Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Prenetics Announces Third Quarter 2024 Financial Results - The Manila Times
Prenetics Global Limited (PRE) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
0.71%
大文字化:
|
ボリューム (24 時間):